Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC cholesterol meter

This article was originally published in The Tan Sheet

Executive Summary

Polymer Technology Systems' CardioChek whole blood chemistry analyzer is now available at 1,200 Wal-Mart stores across the U.S., the company announces Aug 28. Previously sold only online, the meter will now retail for $99.94 in stores under an initial distribution agreement with the retailer. CardioChek is a hand-held analyzer used with separately sold PTS PANELS test strips that are designed to measure whole blood indicators related to heart disease, diabetes and other chronic conditions. Consumers insert a color-coded test strip and roughly 15 mcl of blood into the meter and receive test results within two minutes. The test strips are priced at $11.94 for a package of three tests. Other companies looking to bring cholesterol tests to the OTC arena include International Medical Innovations, which is developing its PREVU Home Test for OTC sale. The product would test skin sterols in order to determine levels of cholesterol. Johnson & Johnson signed an agreement to license IMI's predictive tests in 2004 (1"The Tan Sheet" June 7, 2004, p. 10)...

You may also be interested in...

McNeil Reaches Consumer Cholesterol Testing Licensing Deal With IMI

McNeil Consumer Health is seeking to leverage the potential Rx-to-OTC switch of J&J/Merck's Mevacor (lovastatin) with an agreement to license International Medical Innovations' predictive tests for coronary artery disease (CAD)

Drug/Device Combinations: New Position Paper Explains Notified Body Responsibilities

Medicinal products authorities will consider a medtech notified body opinion on the device element of a drug/device combination product. A new position paper explains how roles and responsibilities are shared between medtech and medicinal product experts.

GC Pharma Aiming To Outrun Rivals For COVID-19 Plasma Therapy

A South Korean pharma firm is set to soon begin pivotal clinical trials for a hyperimmune globulin for the treatment of COVID-19 patients and plans to commercialize the product this year, with a hope of outrunning rivals including Takeda.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts